The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–304 of 304
Bronchodilator delivery in acute airflow obstruction. A meta-analysis
Turner, M. O. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.15.1736 · Cited by 179
Indoor air pollution and health in developing countries
Ezzati, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66845-6 · Cited by 178
Singh, D., Brooks, J., Hagan, G. W., Cahn, A. P., & O'Connor, B. J. (2008) · Thorax · doi:10.1136/thx.2007.087213 · Cited by 176
Self-citationTiotropium + olodaterol shows clinically meaningful improvements in quality of life
Singh, D., Ferguson, G. T., Bolitschek, J., Grönke, L., Hallmann, C., Bennett, N. L., Abrahams, R., Schmidt, O., & Bjermer, L. H. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.08.002 · Cited by 175
Self-citationAugmentation Therapy for α 1 Antitrypsin Deficiency: A Meta-Analysis
Chapman, K. R., Stockley, R. A., Dawkins, C., Wilkes, M. M., & Navickis, R. J. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902905961 · Cited by 171
Self-citationSoriano, J. B., Lamprecht, B., Ramírez, A. S., Martínez‐Camblor, P., Kaiser, B., Alfageme, I., Almagro, P., Casanova, C., Esteban, C., Soler‐Cataluña, J. J., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00157-5 · Cited by 170
Self-citationA Randomized Trial to Improve Communication About End-of-Life Care Among Patients With COPD
Au, D. H., Udris, E. M., Engelberg, R. A., Diehr, P. H., Bryson, C. L., Reinke, L. F., & Curtis, J. R. (2011) · CHEST Journal · doi:10.1378/chest.11-0362 · Cited by 165
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
Mahler, D. A., Decramer, M., D’Urzo, A. D., Worth, H., White, T. A., Alagappan, V. K. T., Chen, H., Gallagher, N. E., Kulich, K. R., & Banerji, D. D. (2013) · European Respiratory Journal · doi:10.1183/09031936.00124013 · Cited by 157
Self-citationStruik, F. M., Lacasse, Y., Goldstein, R. S., Kerstjens, H. A. M., & Wijkstra, P. J. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.10.007 · Cited by 157
Vogiatzis, I., Rochester, C. L., Spruit, M. A., Troosters, T., & Clini, E. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.02151-2015 · Cited by 155
de-Torres, J. P., Wilson, D. O., Sánchez-Salcedo, P., Weissfeld, J. L., Bertó, J., Campo, A., Alcaide, A. B., García‐Granero, M., Celli, B. R., & Zulueta, J. J. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1210oc · Cited by 154
Self-citationHøiseth, A. D., Neukamm, A. M. C., Karlsson, B. D., Omland, T., Brekke, P., & Søyseth, V. (2011) · Thorax · doi:10.1136/thx.2010.153122 · Cited by 154
Crim, C. C., Dransfield, M. T., Bourbeau, J., Jones, P., Hanania, N. A., Mahler, D. A., Vestbo, J., Wachtel, A., Martínez, F. J., Barnhart, F., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201409-413oc · Cited by 152
Self-citationKruis, A. L., Boland, M. R. S., Assendelft, W. J., Gussekloo, J., Tsiachristas, A., Stijnen, T., Blom, C. M. G., Sont, J. K., Mölken, M. R., & Chavannes, N. H. (2014) · BMJ · doi:10.1136/bmj.g5392 · Cited by 150
Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort
Bon, J. M., Fuhrman, C. R., Weissfeld, J. L., Duncan, S. R., Branch, R. A., Chang, C. H., Zhang, Y., Leader, J. K., Gur, D., Greenspan, S. L., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0666oc · Cited by 149
Zhou, Y., Wang, X., Zeng, X.-Y., Qiu, R., Xie, J., Liu, S., Zheng, J., Zhong, N., & Ran, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00897.x · Cited by 147
Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD
Singh, G. K., Zhang, W., Kuo, Y., & Sharma, G. (2015) · CHEST Journal · doi:10.1378/chest.15-0449 · Cited by 147
Short- and Medium-term Prognosis in Patients Hospitalized for COPD Exacerbation
Almagro, P., Soriano, J. B., Cabrera, F. J., Boixeda, R., Ortiz, M. B. A., Barreiro, B., Díez‐Manglano, J., Murio, C., & Heredia, J. L. (2013) · CHEST Journal · doi:10.1378/chest.13-1328 · Cited by 143
Tashkin, D. P., & Fabbri, L. M. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-149 · Cited by 143
Self-citationBarr, R. G., Rowe, B. H., & Camargo, C. A. (2003) · BMJ · doi:10.1136/bmj.327.7416.643 · Cited by 142
Use of Inhaled and Oral Corticosteroids and the Long-term Risk of Cataract
Wang, J. J., Rochtchina, E., Tan, A. G., Cumming, R. G., Leeder, S., & Mitchell, P. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.12.001 · Cited by 141
Oral or IV Prednisolone in the Treatment of COPD Exacerbations
de Jong, Y. P., Uil, S. M., Grotjohan, H. P., Postma, D. S., Kerstjens, H. A. M., & van den Berg, J. W. (2007) · CHEST Journal · doi:10.1378/chest.07-0208 · Cited by 140
Physician Perceptions and Management of COPD
Kesten, S., & Chapman, K. R. (1993) · CHEST Journal · doi:10.1378/chest.104.1.254 · Cited by 140
Goudie, A. R., Lipworth, B. J., Hopkinson, P., Wei, L., & Struthers, A. D. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70013-x · Cited by 139
Thomsen, M., Nordestgaard, B. G., Vestbo, J., & Lange, P. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70137-1 · Cited by 138
Self-citationCardiac dysfunction during exacerbations of chronic obstructive pulmonary disease
MacDonald, M., Shafuddin, E., King, P. T., Chang, C. L., Bardin, P. G., & Hancox, R. J. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00509-3 · Cited by 134
High-risk patients following hospitalisation for an acute exacerbation of COPD
Piquet, J., Chavaillon, J.-M., David, P., Martin, F., Blanchon, F., & Roche, N. (2013) · European Respiratory Journal · doi:10.1183/09031936.00180312 · Cited by 132
Self-citationBronchodilator Delivery in Acute Airflow Obstruction
TURNER, M. O. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360162018 · Cited by 131
Martínez, F. J., Rabe, K. F., Sethi, S., Pizzichini, E., McIvor, A., Anzueto, A., Alagappan, V. K. T., Siddiqui, S. S., Rekeda, L., Miller, C. J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1349oc · Cited by 130
Self-citationPaulin, L. M., Diette, G. B., Blanc, P. D., Putcha, N., Eisner, M. D., Kanner, R. E., Belli, A. J., Christenson, S. A., Tashkin, D. P., Han, M. K., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1407oc · Cited by 126
The Prognostic Importance of Lung Function in Patients Admitted with Heart Failure
Iversen, K. K., Kjærgaard, J., Akkan, D., Køber, L., Torp-Pedersen, C. T., Hassager, C., Vestbo, J., Kjøller, E., & ECHOS Lung Function Study Group (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq050 · Cited by 123
Self-citationvan der Molen, T., & Cazzola, M. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00102 · Cited by 123
Shepard, J., Garrison, M. W., Grither, D. A., Evans, R. G., & Schweitzer, P. K. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90457-7 · Cited by 122
A randomised trial of lung sealant versus medical therapy for advanced emphysema
Come, C. E., Kramer, M. R., Dransfield, M. T., ABU-HIJLEH, M. A., Berkowitz, D. M., Bezzi, M., Bhatt, S. P., Boyd, M. B., Cases, E., Chen, A. C., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00205614 · Cited by 122
Self-citationPro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications
Singh, S., Loke, Y. K., Enright, P., & Furberg, C. D. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201275 · Cited by 121
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk
Jaramillo, J. D., Wilson, C. G., Stinson, D., Lynch, D. A., Bowler, R. P., Lutz, S. M., Bon, J. M., Arnold, B. A., McDonald, M., Washko, G. R., et al. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-591oc · Cited by 120
Mahler, D. A., Kerwin, E., Ayers, T. S., FowlerTaylor, A., Maitra, S., Thach, C. T., Lloyd, M. L., Patalano, F., & Banerji, D. D. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1048oc · Cited by 119
Statin use and exacerbations in individuals with chronic obstructive pulmonary disease
Ingebrigtsen, T. S., Marott, J. L., Nordestgaard, B. G., Lange, P., Hallas, J., & Vestbo, J. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205795 · Cited by 118
Self-citationvan Dijk, W., Tan, W. C., Li, P., Guo, B., Li, S., Benedetti, A., Bourbeau, J., & CanCOLD Study Group (2015) · The Annals of Family Medicine · doi:10.1370/afm.1714 · Cited by 116
Self-citationBateman, E. D., Chapman, K. R., Singh, D., D’Urzo, A. D., Molins, E., Leselbaum, A., & Gil, E. G. (2015) · Respiratory Research · doi:10.1186/s12931-015-0250-2 · Cited by 115
Self-citationThe Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD
Sundh, J., Janson, C., Lisspers, K., Ställberg, B., & Montgomery, S. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00054 · Cited by 114
The Safety of Tiotropium — The FDA's Conclusions
Michele, T. M., Pinheiro, S. P., & Iyasu, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1008502 · Cited by 113
Alía, I. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.530 · Cited by 112
Johnell, O., Pauwels, R., Lofdahl, C., Laitinen, L. A., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00276602 · Cited by 110
Houben‐Wilke, S., Jörres, R. A., Bals, R., Franssen, F. M. E., Gläser, S., Holle, R., Karch, A., Koch, A., MAGNUSSEN, H., Obst, A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0354oc · Cited by 108
Self-citationBronchodilator Use and the Risk of Arrhythmia in COPD
Wilchesky, M., Ernst, P., Brophy, J. M., Platt, R. W., & Suissa, S. (2012) · CHEST Journal · doi:10.1378/chest.11-1597 · Cited by 106
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Miravitlles, M., Kruesmann, F., Haverstock, D. C., Perroncel, R., Choudhri, S. H., & Arvis, P. (2011) · European Respiratory Journal · doi:10.1183/09031936.00042111 · Cited by 101
Jung, K. S., Park, H. Y., Park, S. Y., Kim, S. K., Kim, Y., Shim, J.-J., Moon, H. S., Lee, K. H., Yoo, J.-H., & Lee, S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.004 · Cited by 99
Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
McKay, S., Howie, C., Thomson, A. H., Whiting, B., & Addis, G. J. (1993) · Thorax · doi:10.1136/thx.48.3.227 · Cited by 98
Gavish, R., Levy, A., Kalchiem‐Dekel, O., Karp, E., & Maimon, N. (2015) · CHEST Journal · doi:10.1378/chest.14-1453 · Cited by 94
HIV-associated obstructive lung diseases: insights and implications for the clinician
Drummond, M., & Kirk, G. D. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70017-7 · Cited by 92
Tuberculosis, bronchiectasis and chronic airflow obstruction
Jordan, T., Spencer, E., & Davies, P. D. O. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01749.x · Cited by 90
Hak, E., van Essen, G. A., Buskens, E., Stalman, W. A. B., & MELKER, R. A. D. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.2.120 · Cited by 90
Jennings, J. H., Thavarajah, K., Mendez, M. P., Eichenhorn, M., Kvale, P., & Yessayan, L. (2015) · Chest · doi:10.1378/chest.14-1123 · Cited by 89 · cited 1×
“Lack of spirometric assessment and arterial blood gas analysis have been associated with re-hospitalization and mortality.(293) Mortality relates to patient age, the presence of acidotic respiratory failure, the need for ventilatory support and comorbidities including anxiety and depression.”
BackgroundUse of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza
Dong, Y., Chang, C., Wu, F. L., Shen, L., Calverley, P. M. A., Löfdahl, C., Lai, M., & Mahler, D. A. (2014) · CHEST Journal · doi:10.1378/chest.13-2137 · Cited by 89
Frith, P. A., Thompson, P. J., Ratnavadivel, R., Chang, C. L., Bremner, P. R., Day, P., Frenzel, C., Kurstjens, N., & the Glisten Study Group (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206670 · Cited by 89
Self-citationLong-acting muscarinic antagonists
Melani, A. S. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1058154 · Cited by 88
Nadeem, N. J., Taylor, S. J., & Eldridge, S. M. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-107 · Cited by 85
Jordan, R. E., Majothi, S., Heneghan, N. R., Blissett, D. B., Riley, R. D., Sitch, A. J., Price, M. J., Bates, E. J., Turner, A. M., Bayliss, S. E., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19360 · Cited by 84
Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
Hanania, N. A., Crater, G., Morris, A. N., Emmett, A. H., O’Dell, D. M., & Niewoehner, D. E. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.002 · Cited by 82
Chinese Water-Pipe Smoking and the Risk of COPD
She, J., Yang, P., Wang, Y., Qin, X., Fan, J., Wang, Y., Gao, G., Luo, G., Ma, K., Li, B., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-1499 · Cited by 81
Beta-blockers in COPD: time for reappraisal
Lipworth, B. J., Wedzicha, J. A., Devereux, G. S., Vestbo, J., & Dransfield, M. T. (2016) · European Respiratory Journal · doi:10.1183/13993003.01847-2015 · Cited by 80
Self-citationMasterton, R. G., & Burley, C. J. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00435-6 · Cited by 79
Kesten, S. (2008) · International Journal of COPD · doi:10.2147/copd.s2389 · Cited by 78
Phenotype of Normal Spirometry in an Aging Population
Fragoso, C. A. V., McAvay, G., Ness, P. H. V., Casaburi, R. H., Jensen, R. L., MacIntyre, N. R., Gill, T. M., Yaggi, H. K., & Concato, J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0463oc · Cited by 78
Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
Martinez, C. H., Okajima, Y., Murray, S., Washko, G. R., Martínez, F. J., Silverman, E. K., Lee, J., Regan, E. A., Crapo, J. D., Curtis, J. L., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-62 · Cited by 78
Ulrik, C. S., Ringbæk, T., Laursen, L. C., Green, A., Brøndum, E., & Frausing, E. (2015) · International Journal of COPD · doi:10.2147/copd.s85596 · Cited by 78
Gastro‐esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease
Ingebrigtsen, T. S., Marott, J. L., Vestbo, J., Nordestgaard, B. G., Hallas, J., & Lange, P. (2014) · Respirology · doi:10.1111/resp.12420 · Cited by 73
Self-citationStavem, K., Bjørtuft, Ø., Borgan, Ø., Geiran, O. R., & Boe, J. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.06.025 · Cited by 73
Phenotype of Spirometric Impairment in an Aging Population
Fragoso, C. A. V., McAvay, G., Ness, P. H. V., Casaburi, R. H., Jensen, R. L., MacIntyre, N. R., Yaggi, H. K., Gill, T. M., & Concato, J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1603oc · Cited by 72
Dantic, D. E. (2013) · Health Education Journal · doi:10.1177/0017896912469575 · Cited by 71
Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD
Galli, J. A., Krahnke, J. S., Mamary, A. J., Shenoy, K. V., Zhao, H., & Criner, G. J. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.03.006 · Cited by 68
Self-citationKim, J. H., Yoon, H. I., Oh, Y., Lim, S. Y., Lee, J.-H., Kim, T., Lee, S. Y., Lee, J. H., Lee, S., & Lee, C. (2015) · International Journal of COPD · doi:10.2147/copd.s87766 · Cited by 65
Criner, G. J., & Marchetti, N. T. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1556064 · Cited by 65
Self-citationVarela, M. V. L., de, M. M., Rey, A., Casas, A., Stirbulov, R., Boscio, V. D., & on behalf of the PUMA Team (2016) · Respirology · doi:10.1111/resp.12834 · Cited by 65
Siler, T. M., Kerwin, E., Singletary, K., Brooks, J., & Church, A. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1034256 · Cited by 64
Oga, T., Tsukino, Hajiro, Ikeda, & Nishimura (2011) · International Journal of COPD · doi:10.2147/copd.s24420 · Cited by 62
Goossens, L. M. A., Leimer, I., Metzdorf, N., Becker, K., & Mölken, M. R. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-163 · Cited by 62
Mild prematurity and respiratory functions
Todisco, T., Benedictis, F. M. D., Iannacci, L., Baglioni, S., Eslami, A. R. D., Todisco, E., & Dottorini, M. (1993) · European Journal of Pediatrics · doi:10.1007/bf02072517 · Cited by 59
Cosío, B. G., Shafiek, H., Iglesias, A., Yáñez, A. M., Córdova, R., Palou, A., Rodriguez‐Roisin, R., Peces‐Barba, G., Pascual-Guàrdia, S., Gea, J., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.04.011 · Cited by 58
Self-citationWilson, D. O., Leader, J. K., Fuhrman, C. R., Reilly, J. J., Sciurba, F. C., & Weissfeld, J. L. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318219aa93 · Cited by 54
Davey, C., Zoumot, Z., Jordan, S., Carr, D. H., Polkey, M. I., Shah, P. L., & Hopkinson, N. S. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205127 · Cited by 54
Martínez, F. J., Han, M. K., Flaherty, K. R., & Curtis, J. L. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.101 · Cited by 54
Matamis, D., Tsagourias, M., Papathanasiou, A. I., Sineffaki, H., Lepida, D., Galiatsou, E., & Nakos, G. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.11.011 · Cited by 51
“The unpredictable death”—The last year of life for patients with advanced COPD: Relatives' stories
Ek, K., Andershed, B., Sahlberg‐Blom, E., & Ternestedt, B. (2014) · Palliative & Supportive Care · doi:10.1017/s1478951514001151 · Cited by 46
Li, J., Zheng, J.-P., Yuan, J.-P., Guang-qiao, Z., Zhong, N., & Lin, C.-Y. (2004) · PubMed · Cited by 43
Relapse in FEV1 Decline After Steroid Withdrawal in COPD
Kunz, L. I. Z., Postma, D. S., Klooster, K., Lapperre, T. S., Vonk, J. M., Sont, J. K., Kerstjens, H. A. M., Snoeck-Stroband, J. B., Hiemstra, P. S., & Sterk, P. J. (2015) · CHEST Journal · doi:10.1378/chest.14-3091 · Cited by 41
COPD and disease-specific health status in a working population
Nishimura, K., Mitsuma, S., Kobayashi, A., Yanagida, M., Nakayasu, K., Hasegawa, Y., & Jones, P. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-61 · Cited by 38
Huang, C., Nguyễn, P. A., Kuo, P.-L., Iqbal, U., Hsu, Y.-H. E., & Jian, W. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.05.006 · Cited by 36
Dirven, J. A., Tange, H. J., Muris, J. W. M., van Haaren, K. M., Vink, G., & van Schayck, O. C. P. (2013) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2013.00071 · Cited by 33
Weber, C., Stirnemann, J., Herrmann, F. R., Pautex, S., & Janssens, J.-P. (2014) · BMC Palliative Care · doi:10.1186/1472-684x-13-47 · Cited by 32
Gazzotti, Jardim, Velloso, & Nascimento (2013) · International Journal of COPD · doi:10.2147/copd.s36606 · Cited by 31
What community measurements can be used to predict bone disease in patients with COPD?
Bolton, C. E., Cannings-John, R. L., Edwards, P. H., Ionescu, A.-S., Evans, W. D., Pettit, R. J., Faulkner, T., Stone, M. D., & Shale, D. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.027 · Cited by 27
Hospital and Medical School Planning
Porter, K. R. D. (1962) · BMJ · doi:10.1136/bmj.2.5320.1662 · Cited by 25
Hansen, J. E., & Pórszász, J. (2014) · CHEST Journal · doi:10.1378/chest.14-0437 · Cited by 24
Günen, H., Tarraf, H., NEMATI, A., Ghobain, M. A., Mutairi, S. A., & Bacha, Z. A. (2016) · Tuberkuloz ve Toraks · doi:10.5578/tt.13935 · Cited by 24
Lee, J. H., Kim, H. J., & Kim, Y. H. (2015) · Lung · doi:10.1007/s00408-015-9743-5 · Cited by 22
Zacarias, E. C., Castro, A. A., & Cendon, S. (2007) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132007000200009 · Cited by 22
Mortality of patients with COPD participating in chronic disease management programmes: a happy end?
Peytremann‐Bridevaux, I., Taffé, P., Burnand, B., Bridevaux, P., & Puhan, M. A. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204983 · Cited by 17
Schildmann, E. K., Rémi, C., & Bausewein, C. (2011) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2011.583979 · Cited by 16
E-cigarettes and smoking cessation – Authors' reply
Kalkhoran, S. M., & Glantz, S. A. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30025-x · Cited by 13
Campo, G. C., Napoli, N., Serenelli, C., Tebaldi, M., & Ferrari, R. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.200 · Cited by 12
(2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.127erratum · Cited by 4
Flagged first, then by citations
1 of the 305 references couldn’t be matched to a known paper.
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Singh, D., Agustí, A. G. N., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P. A., Halpin, D. M. G., Han, M. K., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00164-2019 · Cited by 1,994
Self-citationWang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30841-9 · Cited by 1,707
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, D. A., Barnhart, F., Brealey, N., Brooks, J., Criner, G. J., Day, N. C., Dransfield, M. T., Halpin, D. M. G., Han, M. K., JONES, C. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713901 · Cited by 1,257
Self-citationPrevalence, risk factors, and management of asthma in China: a national cross-sectional study
Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31147-x · Cited by 755
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
